Figure 1.
PRISMA 2020 flow diagram for SR addressing the impact of burosumab vs conventional therapy.

PRISMA 2020 flow diagram for SR addressing the impact of burosumab vs conventional therapy.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close